Kaiser Permanante, Northwest Region — Portland, Oregon

Kaiser Permanante, Northwest Region is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Kaiser Permanante, Northwest Region has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanante, Northwest Region?

Kaiser Permanante, Northwest Region has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanante, Northwest Region conducted?

Kaiser Permanante, Northwest Region has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer.

Is Kaiser Permanante, Northwest Region accredited by Crixeo Health?

Kaiser Permanante, Northwest Region has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanante, Northwest Region?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.